Wolfe Research analyst Tim Anderson made two rating changes in the broker’s research coverage of the Pharma and Large Cap ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE